Cardiovascular Risk in Patients with Early Renal Insufficiency: Implications for the Use of ACE Inhibitors

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.2, Iss.3, 2002-01, pp. : 157-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors an asset for advanced renal insufficiency?

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

ACE inhibitors reduce CV risk in patients with atherosclerosis

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Dual ACE and Neutral Endopeptidase Inhibitors: Novel Therapy for Patients with Cardiovascular Disorders

By Tabrizchi R.

Drugs, Vol. 63, Iss. 20, 2003-01 ,pp. : 2185-2202

Adis International

Access to resources Recommend Favorite

Both ACE inhibitors and efonidipine reduce proteinuria in patients with hypertension and renal impairment

Inpharma, Vol. 1, Iss. 1380, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Use of ACE inhibitors and risk of community-acquired pneumonia: a review

By Rafailidis Petros

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 565-573

Springer Publishing Company

Access to resources Recommend Favorite